Steven Simonson
Chief Tech/Sci/R&D Officer bij WINDTREE THERAPEUTICS, INC.
Vermogen: 6 176 $ op 31-03-2024
Actieve functies van Steven Simonson
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| WINDTREE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01-10-2014 | - |
| Corporate Officer/Principal | 20-05-2014 | 01-10-2014 |
Loopbaan van Steven Simonson
Eerdere bekende functies van Steven Simonson
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| AGENNIX AG | Chief Tech/Sci/R&D Officer | 18-04-2011 | 18-04-2011 |
| Corporate Officer/Principal | 02-07-2012 | 01-11-2012 | |
Agennix, Inc.
 Agennix, Inc. Pharmaceuticals: MajorHealth Technology Agennix, Inc. develops drugs for the treatment of cancer and wound healing. It develops liquid formulation of talactoferrin for cancer indications and a topical gel formulation for the treatment of diabetic foot ulcers. The company is headquartered in Houston, TX. | Corporate Officer/Principal | - | 01-11-2012 |
| COVANCE INC. | Corporate Officer/Principal | - | - |
Opleiding van Steven Simonson
| The Medical College of Wisconsin, Inc. | Doctorate Degree |
| Duke University School of Medicine | Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 6 |
| Duitsland | 2 |
Operationeel
| Corporate Officer/Principal | 4 |
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| WINDTREE THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Labcorp Drug Development, Inc.
 Labcorp Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ. | Health Technology |
Agennix, Inc.
Agennix, Inc. Pharmaceuticals: MajorHealth Technology Agennix, Inc. develops drugs for the treatment of cancer and wound healing. It develops liquid formulation of talactoferrin for cancer indications and a topical gel formulation for the treatment of diabetic foot ulcers. The company is headquartered in Houston, TX. | Health Technology |
Agennix AG
 Agennix AG BiotechnologyHealth Technology Agennix AG was a pharmaceutical company, which engaged in the development of protein-based drugs for oncology, asthma and wound healing. Its clinical development programs included oral talactoferrin alfa and RGB-286638. The company was founded in 1993 and was headquartered in Heidelberg, Germany. | Health Technology |
- Beurs
- Insiders
- Steven Simonson
- Ervaring
